Empagliflozin vs Erlotinib

## Empagliflozin vs Erlotinib: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Erlotinib**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Erlotinib**: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Erlotinib — 36 hours.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Erlotinib — C22H23N3O4.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Erlotinib — 393.4380 g/mol.

**Type**: Empagliflozin — Small molecule; Erlotinib — Small molecule.